<unk>  is used for persons with a history of myocardial infarction (heart attack) or persons with peripheral arterial disease. Studies have shown that this medication can reduce the rate of combined endpoint cardiovascular death, MI, stroke, and urgent coronary revascularization.
Vorapaxar
Sesquimustard
Pretomanid
Vagisil
Tezacaftor
Patiromer
Tasimelteon
Enarodustat